| Literature DB >> 25003927 |
Paulo Sérgio da Silva Santos1, Fábio Luiz Coracin2, José Carlos de Almeida Barros3, Marina Helena Cury Gallottini4.
Abstract
OBJECTIVE: To validate the minimal criteria of the histopathologic diagnosis of oral chronic graft-versus-host disease, based on the histopathologic classification of the National Institutes of Health and correlate them with clinical features.Entities:
Mesh:
Year: 2014 PMID: 25003927 PMCID: PMC4891164 DOI: 10.1590/s1679-45082014ao2974
Source DB: PubMed Journal: Einstein (Sao Paulo) ISSN: 1679-4508
Horn's chronic graft-versus-host diseasehistologic classification of oral mucosa and salivary glands(
| Grade I | Mucosa: vacuolization of basal cells, moderate lymphocytic infiltrate, moderate epithelial exocytosis |
| Salivary glands: mild interstitial inflammation | |
| Grade II | Mucosa: epithelial cells with basal vacuolization and dyskeratotic, necrotic keratinocytes with satellitosis, moderate to heavy lymphocytic infiltrate in the submucosa and moderate epithelial exocytosis |
| Salivary glands: mild acinar destruction, ductal dilation, squamous metaplasia, mucous pooling, mild fibrosis, duct cell proliferation, periductal lymphocytic infiltrate | |
| Grade III | Mucosa: focal cleavage between the epithelium and connective tissue, intense lymphocytic infiltrate in the connective tissue, dyskeratotic epithelial cells, lymphocyte exocytosis |
| Salivary glands: marked interstitial lymphocytic infiltrate. Diffuse destruction of ducts and acini | |
| Grade IV | Mucosa: separation of epithelium and the connective tissue |
| Salivary glands: nearly complete loss of acini, dilated ducts, interstitial fibrosis with or without inflammation |
Shulman chronic graft-versus-host diseasehistologic classification of oral mucosa and salivary glands, according to National Institutes of Health Consensus(
| Epithelium | Epithelial thickness (normal, atrophic, hyperkeratosis and acanthosis), presence of vacuolization, apoptosis, spongiosis, atypical keratinocytes, exocytosis of lymphocytes, presence of other inflammatory cells and thickening of basal lamina |
| Lamina propria | Predominant cell type in the inflammatory infiltrate and their distribution in relation to the salivary duct and epithelium |
| Salivary glands | Lymphocytes within the duct, periductal mixed infiltrate, presence of lymphocytes within the acini, apoptosis in the ducts and acini, periductal fibrosis, acinar cell degeneration, interstitial fibrosis, duct ectasia and loss of polarity of epithelial cells of the duct |
Histological classification according to the Horn's( and consensus's Shulman( criteria
| Assessment of biopsies according to Horn's and consensus' grading systems | ||
|---|---|---|
| Horn( | ||
| Grade 0 | 1 (2.5) | |
| Grade I | 4 (9.8) | |
| Grade II | 26 (63.5) | |
| Grade III | 9 (22) | |
| Grade IV | 1 (2.5) | |
| Consensus (Shulman)( | ||
| No cGVHD | 2 (5) | |
| Possible cGVHD | 16 (39) | |
| Consistent with cGVHD | 15 (36.5) | |
| Definitive cGVDH | 8 (20) | |
cGVHD: chronic graft-versus-host disease.
Figure 1Specimens of oral mucosa biopsy taken from patients with oral chronic graft-versus-host disease. (A) Panoramic view of mucosal epithelium and lamina propria with salivary gland lobules. (B) Epithelial hyperplasia and mild inflammatory infiltrate in lamina propria. (C) Ductal ectasia. (D) Periductal fibrosis. (E) Lymphocytes around and migrating into acinar units. (F) High magnification showing periductal mixed chronic infiltrate
Association between clinical grade (Akpek 2001) histological grading (Horn 1995) and consensus (2006)
| Patient | Clinical grading (Akpek 2001) | Histological grading (Horn 1995) | Histological grading Consensus NIH (2006) |
|---|---|---|---|
| 1 | 1 | III | 2 |
| 2 | 1 | II | 1 |
| 3 | 2 | II | 2 |
| 4 | 1 | III | 3 |
| 5 | 2 | I | 1 |
| 6 | 1 | II | 1 |
| 7 | 2 | II | 1 |
| 8 | 2 | IV | 2 |
| 9 | 1 | II | 2 |
| 10 | 1 | II | 3 |
| 11 | 2 | II | 1 |
| 12 | 1 | II | 2 |
| 13 | 1 | II | 2 |
| 14 | 1 | II | 1 |
| 15 | 1 | II | 1 |
| 16 | 1 | II | 2 |
| 17 | 2 | II | 1 |
| 18 | 1 | II | 1 |
| 19 | 1 | II | 1 |
| 20 | 2 | II | 3 |
| 21 | 1 | II | 2 |
| 22 | 2 | II | 3 |
| 23 | 1 | II | 2 |
| 24 | 1 | II | 1 |
| 25 | 1 | III | 3 |
| 26 | 1 | III | 2 |
| 27 | 1 | II | 1 |
| 28 | 1 | III | 2 |
| 29 | 1 | I | 0 |
| 30 | 2 | II | 3 |
| 31 | 1 | II | 1 |
| 32 | 1 | I | 1 |
| 33 | 1 | II | 2 |
| 34 | 0 | 0 | 0 |
| 35 | 1 | II | 2 |
| 36 | 1 | III | 2 |
| 37 | 1 | II | 2 |
| 38 | 1 | I | 1 |
| 39 | 1 | II | 1 |
| 40 | 1 | III | 3 |
| 41 | 1 | III | 3 |
NIH: National Institutes of Health.